Advertisement
BOSTON, Oct. 10, 2018 /PRNewswire-PRWeb/ -- Boston Biotech Conferences, creator of exclusive peer-to-peer CEO meetings for the biotech community, announces the appointment of Wendy Nelson, PhD, as its new CEO.
Dr. Nelson has over 20 years of business development, project management, operational and R&D experience in the biotech industry. Most recently, Dr. Nelson was VP of Business Development, Marketing and Strategic Alliances at Frontage Laboratories. Prior to her decade in business development roles of increasing responsibility, Nelson had roles in project management and operations at Alantos Pharmaceuticals (acquired by Amgen) and R&D at Alkermes. Dr. Nelson is also President & Founder of the Boston Biotech Forum. She has significantly contributed to the life sciences community by building that series into one of the premier content-rich networking events in Boston biotech over the past eight years. In her new role, Dr. Nelson will re-energize the business with substantial developments including rebranding, added leadership, and updated offerings.
"It's an exciting time for this company and I'm thrilled to assume the leadership role. I hope to leverage my experience and passion of running my own Boston Biotech Forum events to re-establishing this business in Boston and across the country. My goal is to continue to build the premier networking and highest quality conferences in the life sciences ecosystem," said Dr. Nelson.
Boston Biotech Conferences recently announced Bob Buderi as the new Chairman. Along with the appointed Ambassador committee under Buderi's chairmanship, Nelson and Buderi will work closely together to help the business better position its offering to shape the future of biotech.
"Wendy is a terrific addition to the team. She brings fantastic insight from an extensive network of experts in life sciences. Her experience in both biotech and biopharma is going to make a monumental impact on this business and its exciting future," said Buderi.
To learn more about the new leadership, click here. Stay tuned for upcoming announcements regarding the company's additional developments.
About Boston Biotech Conferences: Boston Biotech Conferences are exclusive, thought-leader forums for senior biopharma executives. Each conference is highly interactive and co-hosted by healthcare industry leaders to foster discussions and facilitate information-sharing, networking and corporate development within the biopharma community. These meetings convene the most relevant players in biotech to network, collaborate and leverage the experiences of their peers in an off-the-record setting. For more information, please visit: http://www.bostonbiotechconferences.com.
Contact: Boston Biotech Conferences Suzanne Carroll [email protected] +1 857-504-6707
SOURCE Boston Biotech Conferences
Advertisement
Dr. Nelson has over 20 years of business development, project management, operational and R&D experience in the biotech industry. Most recently, Dr. Nelson was VP of Business Development, Marketing and Strategic Alliances at Frontage Laboratories. Prior to her decade in business development roles of increasing responsibility, Nelson had roles in project management and operations at Alantos Pharmaceuticals (acquired by Amgen) and R&D at Alkermes. Dr. Nelson is also President & Founder of the Boston Biotech Forum. She has significantly contributed to the life sciences community by building that series into one of the premier content-rich networking events in Boston biotech over the past eight years. In her new role, Dr. Nelson will re-energize the business with substantial developments including rebranding, added leadership, and updated offerings.
"It's an exciting time for this company and I'm thrilled to assume the leadership role. I hope to leverage my experience and passion of running my own Boston Biotech Forum events to re-establishing this business in Boston and across the country. My goal is to continue to build the premier networking and highest quality conferences in the life sciences ecosystem," said Dr. Nelson.
Boston Biotech Conferences recently announced Bob Buderi as the new Chairman. Along with the appointed Ambassador committee under Buderi's chairmanship, Nelson and Buderi will work closely together to help the business better position its offering to shape the future of biotech.
"Wendy is a terrific addition to the team. She brings fantastic insight from an extensive network of experts in life sciences. Her experience in both biotech and biopharma is going to make a monumental impact on this business and its exciting future," said Buderi.
To learn more about the new leadership, click here. Stay tuned for upcoming announcements regarding the company's additional developments.
About Boston Biotech Conferences: Boston Biotech Conferences are exclusive, thought-leader forums for senior biopharma executives. Each conference is highly interactive and co-hosted by healthcare industry leaders to foster discussions and facilitate information-sharing, networking and corporate development within the biopharma community. These meetings convene the most relevant players in biotech to network, collaborate and leverage the experiences of their peers in an off-the-record setting. For more information, please visit: http://www.bostonbiotechconferences.com.
Contact: Boston Biotech Conferences Suzanne Carroll [email protected] +1 857-504-6707
SOURCE Boston Biotech Conferences
